The DOI matches its Crossref record.
Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency
Abstract
Since 1986, prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21-OHD) have been carried out in 239 pregnancies. In 145, diagnoses were made by amniocentesis, whereas 77 were diagnosed using chorionic villus sampling. A newly developed, rapid allele-specific polymerase chain reaction was used for DNA analysis in some cases. Of 239 pregnancies evaluated, 37 babies were affected with classical 21-OHD. Of these, 21 were females, 13 of whom were treated prenatally with dexamethasone. Dexamethasone administered at or before 10 weeks gestation (9 affected female fetuses) was effective in reducing virilization. Seven fetuses had affected female siblings (Prader stages 1-5); 3 of these were born with entirely normal female genitalia, whereas the other 4 were significantly less virilized (Prader stages 1-2) than their siblings. The remaining 2 newborns had male siblings; 1 was born with normal genitalia, and the other was Prader stage 1. No significant or enduring side-effects were noted in either the mothers or the fetuses, indicating that dexamethasone treatment is safe. Prenatally treated newborns did not differ in weight, length, or head circumference from untreated unaffected newborns. Based on our experience, proper prenatal diagnosis and treatment of 21-OHD is effective in significantly reducing or eliminating virilization in the affected female. This spares the newborn female the consequences of genital ambiguity, i.e. genital surgery, sex misassignment, and gender confusion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TARTs are rare in men with NC CAH (437-439).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [438]
In the citing paper
“In men with CAH, gonadal and reproductive function are often impaired due to primary gonadal failure from TARTs and/or secondary gonadal failure due to suppressed hypothalamicpituitary-gonadal axis as a consequence of high adrenal androgen concentrations (378,437,438,625).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [438]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Still being checked.
Cited by
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Park-Wyllie, L., Mazzotta, P., Pastuszak, A., Moretti, M. E., Beique, L., Hunnisett, L., Friesen, M. H., Jacobson, S., Kasapinovic, S., Chang, D., et al. (2000) · Teratology · doi:10.1002/1096-9926(200012)62:6<385::aid-tera5>3.0.co;2-z · Cited by 955
Glucocorticoids, prenatal stress and the programming of disease
Harris, A., & Seckl, J. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.06.007 · Cited by 871
Prenatal glucocorticoids and long-term programming
Seckl (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.151u049 · Cited by 825
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
SECKL, J. R., & MEANEY, M. J. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1314.006 · Cited by 556
Drake, A., & Walker, B. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1800001 · Cited by 430
Welberg, L. A. M., Seckl, J. R., & Holmes, M. C. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00065-3 · Cited by 420
Glucocorticoid programming of the fetus; adult phenotypes and molecular mechanisms
Seckl, J. R. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00633-5 · Cited by 392
Seckl, J. R. (1997) · Steroids · doi:10.1016/s0039-128x(96)00165-1 · Cited by 298
New, M. I., Carlson, A., Obeid, J., Marshall, I., Cabrera, M. S., Goseco, A., Lin-Su, K., Putnam, A. S., Wei, J. Q., & Wilson, R. C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8072 · Cited by 263
Glucocorticoids, developmental ‘programming’ and the risk of affective dysfunction
Seckl, J. R. (2007) · Progress in Brain Research · doi:10.1016/s0079-6123(07)67002-2 · Cited by 245
Glucocorticoid “Programming” and PTSD Risk
SECKL, J. R., & MEANEY, M. J. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1364.027 · Cited by 234
An update of congenital adrenal hyperplasia
NEW, M. I. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1315.009 · Cited by 178
Adrenal Steroidogenesis and Congenital Adrenal Hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.002 · Cited by 177
Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess
New, M. I., & Wilson, R. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12790 · Cited by 164
Self-citationLong-Term Somatic Follow-Up of Prenatally Treated Children with Congenital Adrenal Hyperplasia1
Lajic, S., Wedell, A., Bui, T.-H., Ritzén, E. M., & Holst, M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5233 · Cited by 164
Meyer-Bahlburg, H. F. L., Dolezal, C., Baker, S. W., Carlson, A. D., Obeid, J. S., & New, M. I. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021129 · Cited by 123
Self-citationHow safe is long-term prenatal glucocorticoid treatment?
Seckl, J. R. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540370067039 · Cited by 118
What Causes Low Rates of Child-Bearing in Congenital Adrenal Hyperplasia?
Meyer-Bahlburg, H. F. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5718 · Cited by 110
Mercè Fernández‐Balsells, M., Muthusamy, K., Smushkin, G., Lampropulos, J. F., Elamin, M. B., Abu Elnour, N. O., Elamin, K. B., Agrwal, N., Gallegos‐Orozco, J. F., Lane, M. A., et al. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03826.x · Cited by 101
Pregnancy outcomes in women with congenital virilizing adrenal hyperplasia
Lo, J. C., & Grumbach, M. M. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70027-6 · Cited by 98
Tardy-Guidollet, V., Menassa, R., Costa, J.-M., David, M., Bouvattier-Morel, C., Baumann, C., Houang, M., Lorenzini, F., Philip, N., Odent, S., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2895 · Cited by 96
De Blasio, M. J., Dodic, M., Jefferies, A. J., Moritz, K. M., Wintour, E. M., & Owens, J. A. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00689.2006 · Cited by 84
Apparent mineralocorticoid excess
Wilson, R. C., Nimkarn, S., & New, M. I. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00356-8 · Cited by 75
Self-citationWedell, A. (1998) · Acta Paediatrica · doi:10.1111/j.1651-2227.1998.tb00968.x · Cited by 73
“Substantial benefit of this prenatal treatment has been reported for severely affected females (23, 24).”
Prenatal treatment of congenital adrenal hyperplasia: risks outweigh benefits
Miller, W. L., & Witchel, S. F. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.10.885 · Cited by 62
Dexamethasone induces germ cell apoptosis in the human fetal ovary
Poulain, M., Frydman, N., Duquenne, C., N′Tumba-Byn, T., Benachi, A., Habert, R., Rouiller-Fabre, V., & Livera, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1681 · Cited by 60
Steroid 21 hydroxylase deficiency congenital adrenal hyperplasia
Nimkarn, S., Lin-Su, K., & New, M. I. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.08.001 · Cited by 52
Self-citationCongenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency
Speiser, P. W., & White, P. C. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00559.x · Cited by 39
Fetal endocrine therapy for congenital adrenal hyperplasia should not be done
Miller, W. L. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.01.005 · Cited by 40
Prenatal genetic testing and treatment for congenital adrenal hyperplasia
Simpson, J. L., & Rechitsky, S. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.11.041 · Cited by 36
Prenatal treatment of congenital adrenal hyperplasia-not standard of care
Witchel, S. F., & Miller, W. L. (2012) · Journal of Genetic Counseling · doi:10.1007/s10897-012-9508-8 · Cited by 29
“…study, six prenatally treated CAH newborns had a mean birth weight of 3.04 kg whereas ten untreated CAH newborns had a mean birth weight of 3.65 kg (Mercado et al. 1995), and a subsequent study reported a mean birth weight of 3.17 kg among 73 prenatally treated CAH newborns, in contrast to a mean…”
ResultInfluentialGorduza, D., Tardy-Guidollet, V., Robert, E., Gay, C.-L., Chatelain, P., David, M., Bretones, P., Lienhardt-Roussie, A., Brac de la Perriere, A., Morel, Y., et al. (2014) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2014.02.003 · Cited by 20
Xu, L., Lin, W., Cai, L., Huang, H., Liang, J., Li, L., Zong, L., Wang, N., Wen, J., & Chen, G. (2020) · Clinical Endocrinology · doi:10.1111/cen.14126 · Cited by 12
Prenatal diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency) in Croatia
Dumić, M., Brkljačić, L., Plavšić, V., Žunec, R., Ille, J., Wilson, R. C., Kuvačić, I., Kaštelan, A., & New, M. I. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19971031)72:3<302::aid-ajmg10>3.0.co;2-x · Cited by 4
Metadata
- Authors
- Mercado, A. B.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1995-07-01
- Volume
- 80
- Issue
- 7
- Pages
- 2014-2020
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2070899628
- Cited by
- 203
- References
- 0
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.